Bayesian Capital Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-62,300
| Closed | -$374K | – | 1190 |
|
2022
Q4 | $374K | Buy |
+62,300
| New | +$374K | 0.05% | 426 |
|
2022
Q3 | – | Sell |
-52,200
| Closed | -$312K | – | 1112 |
|
2022
Q2 | $312K | Buy |
+52,200
| New | +$312K | 0.06% | 470 |
|
2016
Q3 | – | Sell |
-1,620
| Closed | -$6K | – | 616 |
|
2016
Q2 | $6K | Sell |
1,620
-5,990
| -79% | -$22.2K | ﹤0.01% | 385 |
|
2016
Q1 | $40K | Buy |
+7,610
| New | +$40K | 0.04% | 335 |
|